QIP Launch
Initiation: Mankind Pharma has launched a Qualified Institutional Placement (QIP) to raise up to ₹3,000 crore.
Floor Price: The QIP floor price is set at ₹2,616.55 per share.
Market Leadership
The acquisition strengthens Mankind Pharma’s position as a market leader in India’s women’s health and fertility drug segments.
Financing Details
External debt through non-convertible debentures (NCDs) and commercial papers.
Shareholder Approval: Mankind Pharma had earlier secured permission to raise up to ₹10,000 crore for this transaction.